Dx Focus: Vela Diagnostics' Sentosa KRAS Test | GenomeWeb

Vela Diagnostics said this week that its Sentosa SA KRAS PCR Test is now available as a CE-IVD product.

The new test qualitatively assesses mutation status in DNA extracted from colorectal formalin-fixed paraffin-embedded tissues. It detects and differentiates seven mutations (G12A, G12C, G12D, G13D, G12R, G12S and G12V) in codons 12 and 13, which covers more than 97 percent of the known mutations in the KRAS gene.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.